

Frank S. David
Dedicated to exploring the nuances of biotechnology and its intersection with policy and economics, Frank S. David serves as a Professor of the Practice in the Biology Department at Tufts University. With a keen focus on drug development strategy, he brings a wealth of knowledge and experience to his role, guiding students through the complexities of the biotech industry. As the Managing Director of Pharmagellan, a biotech consulting firm, Frank leverages his expertise to optimize the value of innovative R&D for biotech companies, entrepreneurs, and investors. At Tufts University, Frank is deeply involved in teaching and mentoring. He offers courses on drug development, providing students with a comprehensive understanding of the processes and strategies involved in bringing new therapies to market. His commitment to student success is further demonstrated through his coordination of an internship program for biology MS students, where he connects aspiring professionals with valuable industry experience. In addition to his teaching responsibilities, Frank leads seminars on professional skills and career development, equipping students with the tools they need to thrive in their future careers. His research interests lie at the intersection of policy, biotechnology consulting, and economics, where he seeks to address the challenges and opportunities facing the biotech sector today. Frank's contributions to the field extend beyond academia, as he actively engages with industry stakeholders to foster innovation and growth. His work is characterized by a dedication to advancing the understanding and application of biotechnology in ways that benefit both the scientific community and society at large. Through his dual roles in academia and consulting, Frank S. David continues to shape the future of biotechnology and inspire the next generation of leaders in the field.
Publications
, 577-578, 2013-03-16
, 247-252, 2019-09-01
, 51-57, 1987-12-01
, 135-182, 2020-01-01
, 415-415, 1955-12-01